ISLR and gastric cancer: Surprisingly, for the 158 gastric cancer cases treated with 5-Fu-based adjuvant therapy, a high level of ISLR expression was linked to a better clinical prognosis than a low level of ISLR expression (Table 1, HR = 0.63, P = 0.013), indicating a possible connection of ISLR expression with drug sensitivity.